Home › Agent Hub › Agent Tools › Part D coverage by drug › Methocarbamol
Agent Tools
Methocarbamol is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,166 of 5,492 Medicare Part D and Medicare Advantage drug plans (75.9%) list Methocarbamol on their formulary, across 219 of 286 formularies. The most common placement is tier 2 (2,285 plans, 54.8% of those covering it). 894 of the covering plans require prior authorization (21.5%), 0 step therapy and 816 a quantity limit.
2,340 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 1,291 of them $0; 1,826 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 3,985 of 5,496 plans covered it (72.5%); 2027: 4,166 of 5,492 (75.9%).
Of 4,367 plans offered in both years, 104 added it to the formulary and 20 dropped it.
Among plans covering it both years, 67 moved it to a higher tier and 307 to a lower one; 7 added prior authorization and 21 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 214 |
| Tier 2 | 2,285 |
| Tier 3 | 1,346 |
| Tier 4 | 321 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 159 of 323 | 49.2% | 1.9% |
| Medicare Advantage with drugs (MA-PD) | 2,434 of 3,200 | 76.1% | 18.3% |
| Special needs plans (SNP) | 1,573 of 1,969 | 79.9% | 28.3% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 2 | 0 |
| UnitedHealthcare | 757 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 2 | 728 |
| Aetna Medicare | 0 of 631 | No tier listed | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 226 of 226 | Tier 2 | 0 |
| Kaiser Permanente | 112 of 112 | Tier 2 | 16 |
| SCAN Health Plan | 83 of 83 | Tier 2 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 2 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 2 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 4 | 0 |
| Wellpoint | 63 of 63 | Tier 4 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 4 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 2 | 0 |
| Zing Health | 0 of 36 | No tier listed | 0 |
| Capital Blue Cross | 35 of 35 | Tier 4 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 2 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 4 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 2 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 99 of 114 | 86.8% |
| Alaska | 4 of 9 | 44.4% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 127 of 147 | 86.4% |
| Arkansas | 56 of 85 | 65.9% |
| California | 348 of 397 | 87.7% |
| Colorado | 92 of 106 | 86.8% |
| Connecticut | 33 of 54 | 61.1% |
| Delaware | 30 of 43 | 69.8% |
| District of Columbia | 9 of 12 | 75% |
| Florida | 422 of 545 | 77.4% |
| Georgia | 109 of 149 | 73.2% |
| Guam | 0 of 1 | 0% |
| Hawaii | 41 of 50 | 82% |
| Idaho | 33 of 45 | 73.3% |
| Illinois | 84 of 132 | 63.6% |
| Indiana | 107 of 138 | 77.5% |
| Iowa | 42 of 64 | 65.6% |
| Kansas | 54 of 84 | 64.3% |
| Kentucky | 95 of 121 | 78.5% |
| Louisiana | 87 of 125 | 69.6% |
| Maine | 31 of 52 | 59.6% |
| Maryland | 30 of 49 | 61.2% |
| Massachusetts | 62 of 89 | 69.7% |
| Michigan | 145 of 182 | 79.7% |
| Minnesota | 38 of 63 | 60.3% |
| Mississippi | 68 of 104 | 65.4% |
| Missouri | 113 of 170 | 66.5% |
| Montana | 21 of 27 | 77.8% |
| Nebraska | 35 of 51 | 68.6% |
| Nevada | 80 of 100 | 80% |
| New Hampshire | 21 of 25 | 84% |
| New Jersey | 51 of 73 | 69.9% |
| New Mexico | 60 of 68 | 88.2% |
| New York | 141 of 215 | 65.6% |
| North Carolina | 141 of 176 | 80.1% |
| North Dakota | 13 of 26 | 50% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 107 of 171 | 62.6% |
| Oklahoma | 70 of 81 | 86.4% |
| Oregon | 79 of 92 | 85.9% |
| Pennsylvania | 278 of 323 | 86.1% |
| Puerto Rico | 3 of 64 | 4.7% |
| Rhode Island | 20 of 29 | 69% |
| South Carolina | 65 of 89 | 73% |
| South Dakota | 11 of 30 | 36.7% |
| Tennessee | 112 of 156 | 71.8% |
| Texas | 326 of 407 | 80.1% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 43 of 53 | 81.1% |
| Vermont | 8 of 14 | 57.1% |
| Virginia | 124 of 144 | 86.1% |
| Washington | 98 of 114 | 86% |
| West Virginia | 48 of 69 | 69.6% |
| Wisconsin | 78 of 96 | 81.3% |
| Wyoming | 9 of 13 | 69.2% |
Medicare Part D paid for 3,589,636 30-day fills of Methocarbamol in 2024 for about 1,343,132 enrollees, at an average total cost of $8.95 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Methocarbamol and the rest of a client's list on every plan in their county.
Estimate Methocarbamol costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.